BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28371893)

  • 1. Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.
    Shinde AV; Dobaczewski M; de Haan JJ; Saxena A; Lee KK; Xia Y; Chen W; Su Y; Hanif W; Kaur Madahar I; Paulino VM; Melino G; Frangogiannis NG
    Cardiovasc Res; 2017 Jul; 113(8):892-905. PubMed ID: 28371893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
    Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
    J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
    Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
    Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous thrombospondin 1 protects the pressure-overloaded myocardium by modulating fibroblast phenotype and matrix metabolism.
    Xia Y; Dobaczewski M; Gonzalez-Quesada C; Chen W; Biernacka A; Li N; Lee DW; Frangogiannis NG
    Hypertension; 2011 Nov; 58(5):902-11. PubMed ID: 21947471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.
    Frunza O; Russo I; Saxena A; Shinde AV; Humeres C; Hanif W; Rai V; Su Y; Frangogiannis NG
    Am J Pathol; 2016 May; 186(5):1114-27. PubMed ID: 26948424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5.
    Engebretsen KV; Skårdal K; Bjørnstad S; Marstein HS; Skrbic B; Sjaastad I; Christensen G; Bjørnstad JL; Tønnessen T
    J Mol Cell Cardiol; 2014 Nov; 76():148-57. PubMed ID: 25169971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
    Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
    Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.
    Verma SK; Garikipati VNS; Krishnamurthy P; Schumacher SM; Grisanti LA; Cimini M; Cheng Z; Khan M; Yue Y; Benedict C; Truongcao MM; Rabinowitz JE; Goukassian DA; Tilley D; Koch WJ; Kishore R
    Circulation; 2017 Sep; 136(10):940-953. PubMed ID: 28667100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal alterations in cardiac fibroblast function following induction of pressure overload.
    Stewart JA; Massey EP; Fix C; Zhu J; Goldsmith EC; Carver W
    Cell Tissue Res; 2010 Apr; 340(1):117-26. PubMed ID: 20217135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse.
    Balasubramanian S; Quinones L; Kasiganesan H; Zhang Y; Pleasant DL; Sundararaj KP; Zile MR; Bradshaw AD; Kuppuswamy D
    PLoS One; 2012; 7(9):e45076. PubMed ID: 22984613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.
    Gong K; Chen YF; Li P; Lucas JA; Hage FG; Yang Q; Nozell SE; Oparil S; Xing D
    J Hypertens; 2011 Sep; 29(9):1810-9. PubMed ID: 21836474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling.
    Andenæs K; Lunde IG; Mohammadzadeh N; Dahl CP; Aronsen JM; Strand ME; Palmero S; Sjaastad I; Christensen G; Engebretsen KVT; Tønnessen T
    PLoS One; 2018; 13(7):e0201422. PubMed ID: 30052659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Herum KM; Lunde IG; Skrbic B; Louch WE; Hasic A; Boye S; Unger A; Brorson SH; Sjaastad I; Tønnessen T; Linke WA; Gomez MF; Christensen G
    Cardiovasc Res; 2015 May; 106(2):217-26. PubMed ID: 25587045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells.
    Skill NJ; Johnson TS; Coutts IG; Saint RE; Fisher M; Huang L; El Nahas AM; Collighan RJ; Griffin M
    J Biol Chem; 2004 Nov; 279(46):47754-62. PubMed ID: 15326185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis of cell-surface tissue transglutaminase by matrix metalloproteinase-2 contributes to the adhesive defect and matrix abnormalities in thrombospondin-2-null fibroblasts and mice.
    Agah A; Kyriakides TR; Bornstein P
    Am J Pathol; 2005 Jul; 167(1):81-8. PubMed ID: 15972954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.